PLASTICITY AND NEUROPATHOLOGY OF PAIN AND TRANSPLANTS

Information

  • Research Project
  • 2519924
  • ApplicationId
    2519924
  • Core Project Number
    R01NS025054
  • Full Project Number
    5R01NS025054-09
  • Serial Number
    25054
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/1/1987 - 37 years ago
  • Project End Date
    6/20/1998 - 26 years ago
  • Program Officer Name
    KITT, CHERYL A.
  • Budget Start Date
    9/1/1997 - 27 years ago
  • Budget End Date
    6/20/1998 - 26 years ago
  • Fiscal Year
    1997
  • Support Year
    9
  • Suffix
  • Award Notice Date
    9/22/1998 - 25 years ago
Organizations

PLASTICITY AND NEUROPATHOLOGY OF PAIN AND TRANSPLANTS

DESCRIPTION: (Applicant's abstract) Studies in this laboratory and elsewhere have shown that transplants of adrenal chromaffin cells into the spinal subarachnoid space can result in reduction in "pain" behaviors in rat models of persistent pain. In a continuation of this work, experiments are proposed using rats with persistent pain due to experimentally-induced arthritis or sciatic nerve constriction. Two primary goals will be addressed; these are: 1) to assess the safety of adrenal medullary and chromaffin cell transplants in the spinal subarachnoid space; and 2) to clarify the mechanisms of reduction of pain behaviors consequent to adrenal medullary transplants, with particular attention to analysis of the effects on neuroplastic remodeling and long-term neuropathological consequences of chronic pain. The "safety" issue will be addressed by analysis of three factors: 1) motor and other physiological functions; 2) cerebrospinal fluid and blood serum, and 3) neuropathology in spinal cord tissues. The effects of adrenal medullary transplants on functional plasticity in the central nervous system will be examined in the animal pain models with a combination of behavioral measurements and measurements of immediate early gene expression in spinal and supraspinal structures. Evaluation of the benefits of transplants on long-term pathological processes will be examined histologically by analysis of spinal tissues for the presence of hyperchromatic ("dark") neurons and for changes in the numbers of neurons expressing the inhibitory neurotransmitter GABA.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R01
  • Administering IC
    NS
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    NLS
  • Study Section Name
    Neurological Sciences Subcommittee 1
  • Organization Name
    CYTOTHERAPEUTICS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    PROVIDENCE
  • Organization State
    RI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02906
  • Organization District
    UNITED STATES